סולודוקס % 50 וטרינרי
vetmarket ltd, israel - doxycycline hyclate - אבקה להכנת תמיסה - doxycycline hyclate 500 mg/g
סיטרבין להזרקה 1 גרם usp
genmedix - cytarabine 1 g/vial - powder for solution for injection - cytarabine - cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphcytic leukemia of adults and children. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.
נורקורון 10 מ"ג
merck sharp & dohme israel ltd - vecuronium bromide 10 mg/vial - powder for solution for injection - vecuronium - adjunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.
נורקורון 4 מ"ג
merck sharp & dohme israel ltd - vecuronium bromide 4 mg/ml - powder for solution for injection - vecuronium - ajunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.
טרקריום להזרקה
padagis israel agencies ltd, israel - atracurium besylate - תמיסה להזרקה - atracurium besylate 10 mg/ml - atracurium - atracurium - atracurium is a highly selective, competitive or non-depolarising neuromuscular blocking agent which is used as an adjunct to general anaesthesia to enable tracheal intubation to be performed and to relax skeletal muscles during surgery or controlled ventilation.
אינפסורף
rafa laboratories ltd - calfactant as phospholipid - תרחיף - calfactant as phospholipid 35 mg/ml - lung surfactants - infasurf is indicated for the prevention of respiratory distress syndrome (rds) in premature infants at high risk for rds and for the treatment ("rescue") of premature infants who develop rds. infasurf decreases the incidence of rds mortality due to rds and air leaks associated with rds. prophylaxis : prophylaxis therapy at birth with infasurf is indicated for premature infants <29 weeks of gestational age at significant risk for rds. infasurf prophylaxis should be administered as soon as possible preferably within 30 minutes after birth. treatment: infasurf therapy is indicated for infants 72 hours of age with rds (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.
טילמיקוסינגל וטרינרי
biovac ltd., israel - tilmicosin as phosphate - תמיסה - tilmicosin as phosphate 250 mg/ml - treatment of bacterial infections susceptible to tilmicosin in chickens (e.g. pasteurella, ornithobactrium rhinotracheale, stphylococcus, mycoplasma).
פרבליפ 10
unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin